Download CC#5 ConvaTec Silesse Barrier Spray 28ml (Word 25 KB)

PUBLIC SUMMARY DOCUMENT
Product: Silesse Skin Barrier Spray 28 ml
Applicant: ConvaTec (Australia) Pty Ltd
Date of SPAP Meeting: 28 April 2014
1. Proposed Listing on the Stoma Appliance Scheme
The applicant, ConvaTec (Australia) Pty Ltd, sought listing of the Silesse Skin Barrier
Spray (28 ml) in sub-group 9(k) of the Stoma Appliance Scheme (SAS) Schedule. The
product was proposed for listing at the unit price of $14.70, with a maximum monthly
quantity of one unit.
2. Comparator
The applicant nominated Coloplast Brava No Sting Adhesive Barrier Spray, a product
currently listed in SAS sub-group 9(k) with SAS Code 3925N, as the comparator. The
comparator is listed at the unit price of $26.25 for a 50 ml bottle, with a maximum quantity
of six units per year.
3. Background
This was the Stoma Product Assessment Panel (SPAP)’s first consideration of this product.
4. Clinical Place for the Product
SPAP agreed that the proposed product provides an alternative for users requiring a barrier
spray for application to the peristomal skin before an ostomy appliance. However, it was
noted that a broader review of clinical and cost effectiveness is currently being undertaken
for products in Group 9.
5. SPAP Comment
SPAP noted there is no notional benchmark product and associated benchmark price
specified for sub-group 9(k).
Clinical Analysis
The applicant cited that the proposed product is 100 per cent silicone based and alcohol free.
SPAP noted that the nominated comparator has the same features and is therefore
acceptable.
The product is a direct substitute for other barrier spray products currently available in subgroup 9(k).
Economic Analysis
The Panel noted that the price per ml for the comparator is the same as that of the product
under consideration.
Financial Analysis
The applicant has requested a maximum quantity of one 28 ml unit per month (i.e. 336 ml
per year), whereas the comparator is listed at six 50 ml units per year (i.e. 300 ml per year).
While the requested price per ml is the same as the comparator, the maximum annual
quantity is 36 ml more. There could therefore be a cost for the SAS as a consequence of
listing this product under the conditions requested by the applicant.
CC#5
6. SPAP Recommendation
The SPAP recommended that the Silesse Skin Barrier Spray (28 ml) be listed in sub-group
9(k) of the SAS Schedule at a unit price of $14.70, with a maximum monthly quantity of
one unit.
7. Context for Decision
The SPAP helps decide whether stoma products should be subsidised and, if so, the
conditions of their subsidisation in Australia. It considers submissions in this context. An
SPAP decision not to recommend listing or changes to a listing does not represent a final
SPAP view about the merits of a particular stoma product. A company can resubmit to the
SPAP following a decision not to recommend listing or changes to a listing. The SPAP is
an advisory committee and as such its recommendations are non-binding on Government.
All SPAP recommendations are subject to Cabinet/Ministerial approval.
8. Applicant’s Comment
It is noted that based on the comparator used for this submission is 50ml, and the cost
analysis is equal per ml, there are other comparator products currently listed on the SAS at a
higher price for the same volume of 28ml with an allocation of 1 per month (3M No Sting
cavilon no sting barrier film, pump spray 28gm bottle, allocation of 1 per month,$15.31 &
Smith & Nephew No-Sting Skin Prep Spray protective skin barrier spray - 28mL bottle,
allocation of 1per month $15.31). Although there is an excess of 36ml per year, this excess
will not be discarded by the user instead carried over month to month, year to year. Based
on this it would mean that over a longer period of time fewer products per year will be used
and thus minimising cost to the scheme.
CC#5